Cascade
#8 - Kian Sadeghi: Raising $18M to Revolutionise the Future of DNA Sequencing
Kian Sadeghi is the founder and CEO of Nucleus Genomics, a leading biotechnology company revolutionising DNA analysis and health insights through affordable whole-genome sequencing (WGS).
Kian doesn’t have a PhD, is actually a Penn dropout and is only 24.
He’s raised $18 million from the likes of Peter Theil’s Founders Fund and Alexis Ohanian’s Seven Seven Six to capitalise on the plummeting costs of DNA sequencing from $1 billion in 2001 to well below $1,000 today.
Nucleus offers whole-genome sequencing for just $399, plus a $39 annual membership fee, delivering detailed reports on over 800 health conditions, including various cancers, heart diseases, and mental health disorders.
We spoke about
→ his marketing stunt at the Tyson vs Paul fight
→ the importance of intellectual alpha and innovators dilemma
→ the cost of healthcare administration
→ and the future of consumer health companies
Learn more about Kian and his company below:
Remember Everything You Learn from Podcasts
